BACKGROUND: The development of microsurgical techniques has facilitated the establishment of vascularized composite tissue transplant models in small mammals. Because the mouse would be the ideal model to study various composite tissue allotransplantation (CTA)-related problems, we designed two new surgical techniques for orthotopic (ORT) and heterotopic (HET) hind limb transplantation. METHODS: BALB/c hind limbs were transplanted to BALB/c or C57BL6 recipients using a nonsuture cuff technique. ORT: donor femoral vessels were anastomosed to recipient femoral vessels, the sciatic nerve approximated end-to-end and osteosynthesis was performed using an intramedullary rod. HET/cervical: Donor femoral vessels of a reduced size osteomyocutaneous hind limb CTA were anastomosed to recipient common carotid artery and external jugular vein without nerve approximation. RESULTS: Both procedures could be performed with a high success rate (ORT: 62%; HET: 90%). Donor operation lasted for 100±12 min and recipient operation 114±27 min (ORT) and 54±16 min (HET). Complication rates in terms of bleeding, and thrombosis at the cuff side was slightly higher in the ORT group. All syngeneic grafts survived long term (>100 days). FK506 (2 mg/kg) significantly prolonged graft survival (87±22 days) when compared with untreated controls (6±1 day). Functional evaluation of ORT grafts by means of video gait kinematics and CatWalk analysis revealed specific differences of gait parameters when compared with nontransplanted controls (P<0.05). CONCLUSIONS: The ORT hind limb transplant model seems to be best suited to study functional outcome and nerve regeneration in CTA. The technically less demanding HET/cervical model may be used to investigate basic immunology and clinically relevant questions related to acute and chronic rejection, and ischemia reperfusion injury in reconstructive transplantation.
BACKGROUND: The development of microsurgical techniques has facilitated the establishment of vascularized composite tissue transplant models in small mammals. Because the mouse would be the ideal model to study various composite tissue allotransplantation (CTA)-related problems, we designed two new surgical techniques for orthotopic (ORT) and heterotopic (HET) hind limb transplantation. METHODS: BALB/c hind limbs were transplanted to BALB/c or C57BL6 recipients using a nonsuture cuff technique. ORT: donor femoral vessels were anastomosed to recipient femoral vessels, the sciatic nerve approximated end-to-end and osteosynthesis was performed using an intramedullary rod. HET/cervical: Donor femoral vessels of a reduced size osteomyocutaneous hind limb CTA were anastomosed to recipient common carotid artery and external jugular vein without nerve approximation. RESULTS: Both procedures could be performed with a high success rate (ORT: 62%; HET: 90%). Donor operation lasted for 100±12 min and recipient operation 114±27 min (ORT) and 54±16 min (HET). Complication rates in terms of bleeding, and thrombosis at the cuff side was slightly higher in the ORT group. All syngeneic grafts survived long term (>100 days). FK506 (2 mg/kg) significantly prolonged graft survival (87±22 days) when compared with untreated controls (6±1 day). Functional evaluation of ORT grafts by means of video gait kinematics and CatWalk analysis revealed specific differences of gait parameters when compared with nontransplanted controls (P<0.05). CONCLUSIONS: The ORT hind limb transplant model seems to be best suited to study functional outcome and nerve regeneration in CTA. The technically less demanding HET/cervical model may be used to investigate basic immunology and clinically relevant questions related to acute and chronic rejection, and ischemia reperfusion injury in reconstructive transplantation.
Authors: Byoungchol Oh; Georg J Furtmüller; Michael Sosin; Madeline L Fryer; Lawrence J Gottlieb; Michael R Christy; Gerald Brandacher; Amir H Dorafshar Journal: J Vis Exp Date: 2016-01-23 Impact factor: 1.355
Authors: Zuhaib Ibrahim; Damon S Cooney; Jaimie T Shores; Justin M Sacks; Eric G Wimmers; Steven C Bonawitz; Chad Gordon; Dawn Ruben; Stefan Schneeberger; W P Andrew Lee; Gerald Brandacher Journal: J Vis Exp Date: 2013-10-14 Impact factor: 1.355
Authors: Jin U Kang; Yong Huang; Kang Zhang; Zuhaib Ibrahim; Jaepyeong Cha; W P Andrew Lee; Gerald Brandacher; Peter L Gehlbach Journal: J Biomed Opt Date: 2012-08 Impact factor: 3.170
Authors: Georg J Furtmüller; Byoungchol Oh; Johanna Grahammer; Cheng-Hung Lin; Robert Sucher; Madeline L Fryer; Giorgio Raimondi; W P Andrew Lee; Gerald Brandacher Journal: J Vis Exp Date: 2016-02-12 Impact factor: 1.355
Authors: Yong Huang; Georg J Furtmüller; Dedi Tong; Shan Zhu; W P Andrew Lee; Gerald Brandacher; Jin U Kang Journal: PLoS One Date: 2014-12-04 Impact factor: 3.240
Authors: Elisabeth A Kappos; Patricia K Sieber; Patricia E Engels; Alessio V Mariolo; Salvatore D'Arpa; Dirk J Schaefer; Daniel F Kalbermatten Journal: Brain Behav Date: 2017-05-18 Impact factor: 2.708